[Blood coagulation in pancreatic diseases].
D000208:Acute Disease; D000818:Animals; D000991:Antithrombins / Q000032:analysis; D001777:Blood Coagulation / Q000187:drug effects; D004195:Disease Models, Animal; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D004285:Dogs; D004617:Embolism / Q000150:complications; D004655:Emulsions; D005223:Fats; D006474:Hemorrhagic Disorders / Q000209:etiology; D066298:In Vitro Techniques; D008833:Microcirculation; D010182:Pancreatic Diseases / Q000097:blood* / Q000209:etiology; D010190:Pancreatic Neoplasms / Q000150:complications; D010195:Pancreatitis / Q000139:chemically induced; D010973:Platelet Adhesiveness; D011817:Rabbits; D051381:Rats; D012769:Shock / Q000188:drug therapy; D013927:Thrombosis / Q000150:complications; D014357:Trypsin / Q000008:administration & dosage
D000991:Antithrombins; D004655:Emulsions; D005223:Fats; D014357:Trypsin
Blutgerinnung bei Pankreaserkrankungen